Overview

Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
This study will attempt to identify gene and brain activity markers that predict whether people with social anxiety disorder will respond to selective serotonin reuptake inhibitor medications.
Details
Lead Sponsor:
University of Michigan
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Sertraline